The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical efficacy of enfortumab vedotin-pembrolizumab (EV-P) in locally advanced (LA) or metastatic urothelial carcinoma (mUC): A real-world retrospective study.
 
Prateek Jain
No Relationships to Disclose
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Muhammad Umair Anjum
No Relationships to Disclose
 
Muhammad Ali Khan
No Relationships to Disclose
 
Muhammad Umar Afzal
No Relationships to Disclose
 
Ji-Eun Yum
No Relationships to Disclose
 
Kainat Warraich
No Relationships to Disclose
 
Salman Ayub Jajja
No Relationships to Disclose
 
Fnu Swati
No Relationships to Disclose
 
Nikita Tripathi
No Relationships to Disclose
 
Daniel Childs
Employment - Mayo Clinic
Honoraria - Curio Science; International Centers for Precision Oncology Foundation; IntrinsiQ; MJH Life Sciences; Targeted Oncology
Consulting or Advisory Role - Abdera Thereapeutics (Inst); Janssen Biotech (Inst); Novartis (Inst)
Research Funding - Janssen Biotech (Inst)
Travel, Accommodations, Expenses - Prostate Cancer Foundation
 
Jacob Orme
Employment - Mayo Clinic Cancer Center
Consulting or Advisory Role - NaNotics
Patents, Royalties, Other Intellectual Property - Patents regarding PD-L1 cleavage and immunotherapy resistance in multiple cancers. (Inst)
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genzyme; Gilead Sciences; Janssen; Myovant Sciences; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Mark Tyson
Consulting or Advisory Role - AstraZeneca; enGene; ImmunityBio
Research Funding - AstraZeneca (Inst); CG Oncology (Inst); enGene (Inst); Ferring (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); NCI (Inst); pacific edge (Inst); Protara Therapeutics (Inst); Seagen (Inst); SWOG (Inst); Urogen pharma (Inst)
 
Nathan Yu
No Relationships to Disclose
 
Irbaz Riaz
No Relationships to Disclose
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; Gilead Sciences; ImmunityBio; Janssen Oncology; Seagen (Inst); Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen